FRESHPET INC (FRPT) Fundamental Analysis & Valuation

NASDAQ:FRPT • US3580391056

82.64 USD
-2.55 (-2.99%)
At close: Mar 6, 2026
82.64 USD
0 (0%)
After Hours: 3/6/2026, 4:30:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This FRPT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall FRPT gets a fundamental rating of 5 out of 10. We evaluated FRPT against 88 industry peers in the Food Products industry. FRPT has only an average score on both its financial health and profitability. While showing a medium growth rate, FRPT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. FRPT Profitability Analysis

1.1 Basic Checks

  • In the past year FRPT was profitable.
  • In the past year FRPT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: FRPT reported negative net income in multiple years.
  • Of the past 5 years FRPT 4 years had a positive operating cash flow.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

  • FRPT's Return On Assets of 7.83% is amongst the best of the industry. FRPT outperforms 89.77% of its industry peers.
  • Looking at the Return On Equity, with a value of 11.51%, FRPT is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
  • The Return On Invested Capital of FRPT (4.41%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 7.83%
ROE 11.51%
ROIC 4.41%
ROA(3y)2.84%
ROA(5y)-0.11%
ROE(3y)4.14%
ROE(5y)0.51%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • With an excellent Profit Margin value of 12.63%, FRPT belongs to the best of the industry, outperforming 94.32% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 8.62%, FRPT is in the better half of the industry, outperforming 71.59% of the companies in the same industry.
  • FRPT's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 40.89%, FRPT belongs to the top of the industry, outperforming 93.18% of the companies in the same industry.
  • In the last couple of years the Gross Margin of FRPT has declined.
Industry RankSector Rank
OM 8.62%
PM (TTM) 12.63%
GM 40.89%
OM growth 3YN/A
OM growth 5Y13.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.7%
GM growth 5Y-1.75%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. FRPT Health Analysis

2.1 Basic Checks

  • FRPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, FRPT has more shares outstanding
  • FRPT has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, FRPT has an improved debt to assets ratio.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • FRPT has an Altman-Z score of 5.33. This indicates that FRPT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.33, FRPT belongs to the top of the industry, outperforming 89.77% of the companies in the same industry.
  • FRPT has a debt to FCF ratio of 34.56. This is a negative value and a sign of low solvency as FRPT would need 34.56 years to pay back of all of its debts.
  • FRPT has a Debt to FCF ratio (34.56) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.35 indicates that FRPT is not too dependend on debt financing.
  • FRPT's Debt to Equity ratio of 0.35 is in line compared to the rest of the industry. FRPT outperforms 57.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 34.56
Altman-Z 5.33
ROIC/WACC0.54
WACC8.14%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • FRPT has a Current Ratio of 5.54. This indicates that FRPT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.54, FRPT belongs to the top of the industry, outperforming 93.18% of the companies in the same industry.
  • FRPT has a Quick Ratio of 4.57. This indicates that FRPT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.57, FRPT belongs to the top of the industry, outperforming 93.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.54
Quick Ratio 4.57
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. FRPT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 210.64% over the past year.
  • Looking at the last year, FRPT shows a quite strong growth in Revenue. The Revenue has grown by 13.01% in the last year.
  • FRPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.15% yearly.
EPS 1Y (TTM)210.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
Revenue 1Y (TTM)13.01%
Revenue growth 3Y22.79%
Revenue growth 5Y28.15%
Sales Q2Q%8.57%

3.2 Future

  • Based on estimates for the next years, FRPT will show a small growth in Earnings Per Share. The EPS will grow by 4.79% on average per year.
  • Based on estimates for the next years, FRPT will show a quite strong growth in Revenue. The Revenue will grow by 9.84% on average per year.
EPS Next Y-49.38%
EPS Next 2Y-13.22%
EPS Next 3Y-4.23%
EPS Next 5Y4.79%
Revenue Next Year9.24%
Revenue Next 2Y9.3%
Revenue Next 3Y10.06%
Revenue Next 5Y9.84%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. FRPT Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 28.30, FRPT can be considered very expensive at the moment.
  • FRPT's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 26.69. FRPT is around the same levels.
  • FRPT is valuated quite expensively with a Price/Forward Earnings ratio of 55.90.
  • FRPT's Price/Forward Earnings is on the same level as the industry average.
  • FRPT is valuated expensively when we compare the Price/Forward Earnings ratio to 24.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.3
Fwd PE 55.9
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 60.23% of the companies in the same industry are cheaper than FRPT, based on the Enterprise Value to EBITDA ratio.
  • FRPT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 327.57
EV/EBITDA 23.44
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The decent profitability rating of FRPT may justify a higher PE ratio.
  • FRPT's earnings are expected to decrease with -4.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.22%
EPS Next 3Y-4.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FRPT Dividend Analysis

5.1 Amount

  • No dividends for FRPT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FRPT Fundamentals: All Metrics, Ratios and Statistics

FRESHPET INC

NASDAQ:FRPT (3/6/2026, 4:30:00 PM)

After market: 82.64 0 (0%)

82.64

-2.55 (-2.99%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners119.68%
Inst Owner Change0.05%
Ins Owners1.82%
Ins Owner Change6.29%
Market Cap4.05B
Revenue(TTM)1.10B
Net Income(TTM)139.14M
Analysts77.39
Price Target80.78 (-2.25%)
Short Float %11.26%
Short Ratio4.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)194.38%
Min EPS beat(2)68.44%
Max EPS beat(2)320.31%
EPS beat(4)3
Avg EPS beat(4)134.05%
Min EPS beat(4)-9.66%
Max EPS beat(4)320.31%
EPS beat(8)6
Avg EPS beat(8)117.47%
EPS beat(12)9
Avg EPS beat(12)119.55%
EPS beat(16)10
Avg EPS beat(16)76.43%
Revenue beat(2)0
Avg Revenue beat(2)-1.25%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-0.37%
Revenue beat(4)0
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)-0.37%
Revenue beat(8)2
Avg Revenue beat(8)-0.95%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)-0.07%
PT rev (1m)8.06%
PT rev (3m)5.5%
EPS NQ rev (1m)-0.99%
EPS NQ rev (3m)-7.19%
EPS NY rev (1m)0.63%
EPS NY rev (3m)-21.11%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.22%
Valuation
Industry RankSector Rank
PE 28.3
Fwd PE 55.9
P/S 3.68
P/FCF 327.57
P/OCF 25.25
P/B 3.35
P/tB 3.35
EV/EBITDA 23.44
EPS(TTM)2.92
EY3.53%
EPS(NY)1.48
Fwd EY1.79%
FCF(TTM)0.25
FCFY0.31%
OCF(TTM)3.27
OCFY3.96%
SpS22.46
BVpS24.64
TBVpS24.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40.23
Profitability
Industry RankSector Rank
ROA 7.83%
ROE 11.51%
ROCE 5.59%
ROIC 4.41%
ROICexc 5.28%
ROICexgc 5.28%
OM 8.62%
PM (TTM) 12.63%
GM 40.89%
FCFM 1.12%
ROA(3y)2.84%
ROA(5y)-0.11%
ROE(3y)4.14%
ROE(5y)0.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y8.71%
ROICexc growth 3YN/A
ROICexc growth 5Y8.71%
OM growth 3YN/A
OM growth 5Y13.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.7%
GM growth 5Y-1.75%
F-Score8
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 34.56
Debt/EBITDA 2.3
Cap/Depr 165.16%
Cap/Sales 13.45%
Interest Coverage 8.24
Cash Conversion 86.94%
Profit Quality 8.9%
Current Ratio 5.54
Quick Ratio 4.57
Altman-Z 5.33
F-Score8
WACC8.14%
ROIC/WACC0.54
Cap/Depr(3y)275.97%
Cap/Depr(5y)510.14%
Cap/Sales(3y)21.27%
Cap/Sales(5y)35.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)210.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
EPS Next Y-49.38%
EPS Next 2Y-13.22%
EPS Next 3Y-4.23%
EPS Next 5Y4.79%
Revenue 1Y (TTM)13.01%
Revenue growth 3Y22.79%
Revenue growth 5Y28.15%
Sales Q2Q%8.57%
Revenue Next Year9.24%
Revenue Next 2Y9.3%
Revenue Next 3Y10.06%
Revenue Next 5Y9.84%
EBIT growth 1Y141.73%
EBIT growth 3YN/A
EBIT growth 5Y45.23%
EBIT Next Year185.1%
EBIT Next 3Y58.17%
EBIT Next 5Y40.5%
FCF growth 1Y137.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.07%
OCF growth 3YN/A
OCF growth 5Y49.93%

FRESHPET INC / FRPT FAQ

What is the ChartMill fundamental rating of FRESHPET INC (FRPT) stock?

ChartMill assigns a fundamental rating of 5 / 10 to FRPT.


What is the valuation status for FRPT stock?

ChartMill assigns a valuation rating of 2 / 10 to FRESHPET INC (FRPT). This can be considered as Overvalued.


How profitable is FRESHPET INC (FRPT) stock?

FRESHPET INC (FRPT) has a profitability rating of 6 / 10.


What is the valuation of FRESHPET INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESHPET INC (FRPT) is 28.3 and the Price/Book (PB) ratio is 3.35.


How financially healthy is FRESHPET INC?

The financial health rating of FRESHPET INC (FRPT) is 6 / 10.